Real-world colonoscopy benefit seen more limited

NEW YORK (Reuters Health) - Screening for colorectal cancer by colonoscopy seems to prevent about two-thirds of deaths from colon cancer, rather than 90 percent as has been widely claimed, a study indicates.

In fact, the results show that the benefit of colonoscopy in preventing deaths from colorectal cancer is largely limited to malignancies that occur on the left side of the colon.

“While colonoscopy remains the gold standard for evaluation of the colon, our study sheds light on some of the real-world limitations of this practice for screening and prevention,” lead author Dr. Nancy Baxter, from the University of Toronto, said in a statement.

The large bowel extends from the rectum up the left side of the abdomen, across, and down the right side to the cecum, or junction with the small intestine. Although the entire colon should be inspected during a colonoscopy, the cecum and the right side of the colon can be difficult to reach during insertion of the colonoscope.

The current study, based in Ontario, Canada, included more than 10,000 patients who were diagnosed with colorectal cancer between 1996 and 2001 and died from the malignancy by the end of 2003. Each patient was matched to five “controls” who did not have colorectal cancer.

Overall, 9.8 percent of controls had undergone colonoscopy compared with only 7.0 percent of the patients who died of colorectal cancer, the researchers report in the Annals of Internal Medicine.

Complete colonoscopy (that is, to the cecum) was associated with a 67 percent reduced risk of death from left-sided colorectal cancer, but was not associated with a significant reduction in deaths from right-sided disease.

One reason for this may be that the colonoscopies were not as complete as reported, or were hurried, Dr. David F. Ransohoff, from the University of North Carolina, Chapel Hill, suggests in an accompanying editorial.

He comments, “Colonoscopy is an effective intervention, but as Baxter and colleagues suggest, we must realize that current evidence is indirect and does not support a claim of 90 percent effectiveness.”

Ransohoff adds that, in advising patients about colonoscopy, “we should be realistic and cautious when talking with them about the magnitude of both benefits and risks.”

SOURCE: Annals of Internal Medicine, January 6, 2009, released online December 15, 2008.


Related Posts:

By Will Boggs, MD NEW YORK (Reuters Health) - The surgical removal of small colon polyps found during computed tomography imaging of the colon, or CT colonography, is costly and unnecessary, according to a new study. “We shouldn’t aggressively pursue sub-centimeter lesions, since the costs, risks, and inconvenience of the subsequent colonoscopy outweighs the clinical importance of

Full Post: Removing small colon polyps costly, unnecessary

By Will Dunham WASHINGTON (Reuters) - Primary-care doctors perform colonoscopies just as well as specialists, a finding that could help meet the rising need for this important colorectal cancer screening test, U.S. researchers said on Monday. As populations in the United States and other nations age, the number of people who could benefit from a colonoscopy is

Full Post: Primary-care doctors do colonoscopies well: study

By Will Dunham WASHINGTON (Reuters) - Colorectal cancer diagnoses and deaths have fallen in the United States this decade, but the gap in progress between whites and blacks is widening, the American Cancer Society said on Monday. Improvement has come about chiefly due to prevention and early detection through colonoscopy and other screening methods recommended starting at

Full Post: U.S. blacks lag whites in colorectal cancer progress

LONDON (Reuters) - A national screening program in Finland has detected about 40 percent of colon cancers early, showing that such tests can make a difference, Finnish researchers reported on Friday. Researchers studied 106,000 men and women aged between 60 and 64 across Finland to examine the effectiveness of a colon cancer screening program started in

Full Post: Study backs Finland’s colon cancer screening

By David Douglas NEW YORK (Reuters Health) - A simplified colorectal cancer screening test that detects tumor DNA in stool is an improvement over an earlier-generation assay, according to North American researchers. “This new version of the stool DNA test offers rather high sensitivity for colorectal cancer using a much simpler assay,” lead investigator Dr. Steven Itzkowitz

Full Post: Improved stool DNA test helps spot colon cancer

Site Navigation

Most Read